Allogeneic haematopoietic stem cell transplantation after reduced-intensity conditioning regimen from Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC):: study of pre-transplant and post-transplant factors on outcome

被引：0
|
作者：
Michallet, M
Le, Q
Chir, Z
Bilger, K
Attal, M
Huyn, A
Blaise, D
Milpied, N
Moreau, P
Bordigoni, P
Kuentz, M
Sadoun, A
Cahn, JY
Socie, G
Fürst, S
Thomas, X
Michallet, AS
Jouet, JP
Boiron, JM
机构：
[1] Hop Edouard Herriot, Lyon, France
[2] Inst J Paoli I Calmettes, SFGM TC, Marseille, France
[3] Hop Purpan, Toulouse, France
[4] Hop Hotel Dieu, F-75181 Paris, France
[5] Hop Brabois, Vandoeuvre Les Nancy, France
[6] Hop Henri Mondor, F-94010 Creteil, France
[7] Hop La Miletrie, Poitiers, France
[8] Hop Jean Minjoz, F-25030 Besancon, France
[9] Hop St Louis, Paris, France
[10] Hop Claude Huriez, Lille, France
[11] Hop Haut LEveque, Pessac, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] Reduced-intensity conditioning (RIC) regimen followed by allogeneic stem cell transplantation (alloSCT) for relapsed or refractory diffuse large B-cell lymphoma (DLCL). A retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) registry.
    Sirvent, Anne
    Hummelsberger, Michael
    Chir, Zina
    Dhedin, Nathalie
    Faucher, Catherine
    Jouet, Jean-Pierre
    Attal, Michel
    Chevalier, Patrice
    Robin, Marie
    Tabrizi, Reza
    Bordigoni, Pierre
    Bourhis, Jean-Henri
    Buzyn, Agnes
    Contentin, Nathalie
    Cornillon, Jerome
    Garban, Frederic
    Michallet, Mauricette
    BLOOD, 2006, 108 (11) : 834A - 834A
  • [22] Pre-transplantation risk factors for the development of sclerotic chronic GvHD after allogeneic HSCT: A multicentre retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Detrait, M.
    de la Tour, R. Peffault
    Yacoub-Agha, I.
    Crocchiolo, R.
    Vigouroux, S.
    Bay, J.
    Chevalier, P.
    Sobh, M.
    Morisset, S.
    Raus, N.
    Barraco, F.
    Labussiere, H.
    Tabrizi, R.
    Magro, L.
    Mohty, M.
    Milpied, N.
    Blaise, D.
    Socie, G.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S46 - S47
  • [23] Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Societe Francaise des Cancers de l'Enfant and the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Paillard, C.
    Rochette, E.
    Lutz, P.
    Bertrand, Y.
    Michel, G.
    Bordigoni, P.
    Dalle, J. H.
    Rohrlich, P.
    Vannier, J. P.
    Perel, Y.
    Plantaz, D.
    Leverger, G.
    Sirvent, A.
    Dore, E.
    Isfan, F.
    Merlin, E.
    Pereira, B.
    Halle, P.
    Rabiau, N.
    Kanold, J.
    Demeocq, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1401 - 1408
  • [24] Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Mamez, A-C
    Levy, V.
    Chevallier, P.
    Blaise, D.
    Vigouroux, S.
    Xhaard, A.
    Fegueux, N.
    Contentin, N.
    Beguin, Y.
    Ifrah, N.
    Bulabois, C-E
    Suarez, F.
    Yakoub-Agha, I.
    Turlure, P.
    Deconink, E.
    Lamy, T.
    Cahn, J. Y.
    Huynh, A.
    Maury, S.
    Fornecker, L. M.
    Ouzegdouh, M.
    Bay, J-O
    Guillerm, G.
    Maillard, N.
    Michallet, M.
    Malfuson, J-V
    Bourhis, J-H
    Rialland, F.
    Oumedaly, R.
    Jubert, C.
    Leblond, V.
    Boubaya, M.
    Mohty, M.
    Nguyen, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 358 - 364
  • [25] Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Detrait, M. Y.
    Morisset, S.
    de Latour, R. Peffault
    Yakoub-Agha, I.
    Crocchiolo, R.
    Tabrizi, R.
    Bay, J-O
    Chevalier, P.
    Barraco, F.
    Raus, N.
    Vigouroux, S.
    Magro, L.
    Mohty, M.
    Milpied, N.
    Blaise, D.
    Socie, G.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 (02) : 253 - 258
  • [26] Updated analysis of hematopoietic stem cell transplantations after reduced intensity conditioning regimen (RIC HSCT) for hematological malignancies from the Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire (SFGM-TC) registry.
    Michallet, M
    Le, QH
    Prebet, T
    Mohty, M
    Boiron, JM
    Esperou, HN
    Milpied, N
    Dhédin, N
    Blaise, D
    BLOOD, 2005, 106 (11) : 18A - 18A
  • [27] Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)
    Decroocq, Justine
    Itzykson, Raphael
    Vigouroux, Stephane
    Michallet, Mauricette
    Yakoub-Agha, Ibrahim
    Beckerich, Florence
    Huynh, Anne
    Suarez, Felipe
    Chevallier, Patrice
    Quoc, Stephanie Nguyen
    Lioure, Bruno
    Clement, Laurence
    Fegueux, Nathalie
    Contentin, Nathalie
    Guillerm, Gaelle
    Cornillon, Jerome
    Carre, Martin
    Maillard, Natacha
    Mercier, Melanie
    Mohty, Mohamad
    Beguin, Yves
    Bourhis, Jean-Henri
    Charbonnier, Amandine
    Jubert, Charlotte
    Dauriac, Charles
    Bay, Jacques-Olivier
    Blaise, Didier
    Deconinck, Eric
    Raus, Nicole
    de la Tour, Regis Peffault
    Dhedin, Nathalie
    BLOOD, 2015, 126 (23)
  • [28] Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Societe Francophone de Greffe de Moelle et de Therapie cellulaire (SFGM-TC) multicentre cohort study
    Xhaard, Alienor
    Xhaard, Constance
    D'Aveni, Maud
    Salvator, Helene
    Chabi, Marie-Laure
    Berceanu, Ana
    Coman, Tereza
    Beguin, Yves
    Chalandon, Yves
    Poire, Xavier
    Loschi, Michael
    Paillard, Catherine
    Bruno, Benedicte
    Ceballos, Patrice
    Dalle, Jean-Hugues
    Bilger, Karin
    Bay, Jacques-Olivier
    Robin, Marie
    N'Guyen-Quoc, Stephanie
    Rubio, Marie-Therese
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) : E121 - E124
  • [29] Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)
    Mohty, Mohamad
    Vernant, Jean-Paul
    Yakoub-Agha, Ibrahim
    Blaise, Didier
    Socie, Gerard
    Cordonnier, Catherine
    Deconinck, Eric
    Bourhis, Jean-Henri
    Guilhot, Francois
    Buzyn, Agnes
    Ifrah, Norbert
    Guyotat, Denis
    Harousseau, Jean-Luc
    Sutton, Laurent
    Milpied, Noel-Jean
    Michallet, Mauricette
    BLOOD, 2009, 114 (22) : 87 - 88
  • [30] UPDATED ANALYSIS OF ALLOGENEIC HSCT AFTER RIC FOR HEMATOLOGICAL MALIGNANCIES FROM THE SOCIETE FRANCAISE DE GREFFE DE MOELLE OSSEUSE ET DE THERAPIE CELLULAIRE (SFGM-TC) REGISTRY
    Michallet, M.
    Michallet, M.
    Le, Q.
    Mohty, M.
    Sobh, M.
    Nicolini, F. E.
    Boiron, J. -M.
    Esperou, H.
    Attal, M.
    Milpied, N.
    Lioure, B.
    Bordigoni, P.
    Yackoub-Agha, I.
    Bourhis, J.
    Rio, B.
    Deconninck, E.
    Renaud, M.
    Raus, N.
    Blaise, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 166 - 166
12345